William Blair & Company’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$498K Buy
2,251
+583
+35% +$143K ﹤0.01% 1160
2025
Q4
$423K Sell
1,668
-103
-6% -$25.9K ﹤0.01% 1199
2025
Q3
$438K Sell
1,771
-177
-9% -$42.4K ﹤0.01% 1159
2025
Q2
$468K Buy
1,948
+235
+14% +$54.7K ﹤0.01% 1102
2025
Q1
$388K Sell
1,713
-106
-6% -$23.3K ﹤0.01% 1160
2024
Q4
$374K Sell
1,819
-1,057
-37% -$232K ﹤0.01% 1195
2024
Q3
$698K Sell
2,876
-771
-21% -$180K ﹤0.01% 1018
2024
Q2
$801K Sell
3,647
-1,059
-23% -$230K ﹤0.01% 950
2024
Q1
$1.06M Sell
4,706
-3,787
-45% -$854K ﹤0.01% 846
2023
Q4
$1.87M Sell
8,493
-7,944
-48% -$1.68M 0.01% 684
2023
Q3
$3.61M Buy
16,437
+474
+3% +$107K 0.01% 512
2023
Q2
$3.59M Buy
15,963
+2,432
+18% +$487K 0.01% 513
2023
Q1
$2.59M Buy
13,531
+695
+5% +$134K 0.01% 598
2022
Q4
$2.37M Sell
12,836
-1,581
-11% -$278K 0.01% 586
2022
Q3
$2.4M Buy
14,417
+750
+5% +$153K 0.01% 571
2022
Q2
$2.82M Buy
13,667
+144
+1% +$32.5K 0.01% 552
2022
Q1
$3.27M Buy
13,523
+1,010
+8% +$234K 0.01% 571
2021
Q4
$3.05M Buy
12,513
+995
+9% +$227K 0.01% 613
2021
Q3
$2.35M Buy
11,518
+456
+4% +$97.6K 0.01% 666
2021
Q2
$2.28M Buy
11,062
+959
+9% +$193K 0.01% 676
2021
Q1
$1.92M Buy
10,103
+1,133
+13% +$210K 0.01% 704
2020
Q4
$1.7M Buy
8,970
+2,439
+37% +$455K 0.01% 698
2020
Q3
$1.15M Buy
6,531
+1,049
+19% +$168K ﹤0.01% 718
2020
Q2
$841K Buy
5,482
+60
+1% +$9.14K ﹤0.01% 772
2020
Q1
$759K Buy
5,422
+1,283
+31% +$192K ﹤0.01% 747
2019
Q4
$631K Buy
4,139
+2,635
+175% +$386K ﹤0.01% 918
2019
Q3
$217K Buy
1,504
+120
+9% +$17.9K ﹤0.01% 1238
2019
Q2
$206K Buy
+1,384
New +$185K ﹤0.01% 1300
2018
Q4
Sell
-2,129
Closed -$244K 1777
2018
Q3
$244K Hold
2,129
﹤0.01% 1220
2018
Q2
$224K Buy
+2,129
New +$214K ﹤0.01% 1234
2015
Q4
Sell
-3,095
Closed -$200K 1271
2015
Q3
$200K Buy
+3,095
New +$204K ﹤0.01% 1285

Other funds holding STE

William Blair & Company's STE Position: Q1 2026 in Review

William Blair & Company increased its Steris (STE) stake by 35% in Q1 2026, buying an estimated $143K and bringing the position to 2,251 shares worth $498K. The position accounts for ﹤0.01% of the portfolio, ranked #1160.

William Blair & Company first reported a position in STE in Q3 2015 and has held it in 31 quarters since. The position peaked at $3.61M in Q3 2023. 840 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • William Blair & Company held 2,251 shares of Steris worth $498K as of Q1 2026.
  • William Blair & Company bought 583 Steris shares in Q1 2026, an estimated $143K.
  • Steris made up ﹤0.01% of William Blair & Company's portfolio in Q1 2026, its #1160 holding.
  • William Blair & Company first reported a position in Steris in Q3 2015 and has held it in 31 quarters since.
  • William Blair & Company's Steris position peaked at $3.61M in Q3 2023.
  • 840 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.